Standard Biotools (LAB) Amortization of Deferred Charges (2017 - 2023)
Standard Biotools (LAB) reported Amortization of Deferred Charges of $173000.0 for Q4 2023, down 14.36% year-over-year from $202000.0 in Q4 2022, and down 7.49% on a QoQ basis from $187000.0 in Q3 2023.
Standard Biotools (LAB) has 7 years of Amortization of Deferred Charges data on file, last reported at $173000.0 in Q4 2023.
- Quarterly Amortization of Deferred Charges fell 14.36% year-over-year to $173000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $770000.0 (down 7.23% YoY) and the FY2023 annual result came in at $770000.0, down 7.23% from the prior year.
- Amortization of Deferred Charges eased to $173000.0 in Q4 2023 per LAB's latest filing, from $187000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $2.0 million in Q1 2019 and bottomed at -$194000.0 in Q4 2019.
- The 5-year median for Amortization of Deferred Charges is $194500.0 (2022), against an average of $269500.0.
- The widest annual swing landed in 2019, when Amortization of Deferred Charges plunged 107.28%; it then surged 205.0% in 2021.
- Tracing LAB's Amortization of Deferred Charges over 5 years: stood at -$194000.0 in 2019, then surged by 167.01% to $130000.0 in 2020, then jumped by 228.46% to $427000.0 in 2021, then tumbled by 52.69% to $202000.0 in 2022, then fell by 14.36% to $173000.0 in 2023.
- Per Business Quant, the three latest LAB Amortization of Deferred Charges figures stand at $173000.0 (Q4 2023), $187000.0 (Q3 2023), and $206000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 173,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Dec 31, 2022 | 202,000.00 |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 211,000.00 |
| Mar 31, 2022 | 211,000.00 |
| Sep 30, 2021 | 427,000.00 |
| Sep 30, 2021 | 427,000.00 |
| Jun 30, 2021 | 211,000.00 |
| Jun 30, 2021 | 211,000.00 |
| Mar 31, 2021 | 132,000.00 |
| Mar 31, 2021 | 132,000.00 |
| Dec 31, 2020 | 130,000.00 |
| Dec 31, 2020 | 130,000.00 |
| Sep 30, 2020 | 140,000.00 |
| Sep 30, 2020 | 140,000.00 |
| Jun 30, 2020 | 135,000.00 |
| Jun 30, 2020 | 135,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Dec 31, 2019 | -194,000.00 |
| Dec 31, 2019 | -194,000.00 |
| Sep 30, 2019 | 93,000.00 |
| Sep 30, 2019 | 93,000.00 |
| Mar 31, 2019 | 2.04 Mn |
| Mar 31, 2019 | 2.04 Mn |
| Dec 31, 2018 | 2.66 Mn |
| Dec 31, 2018 | 2.66 Mn |
| Sep 30, 2018 | 2.63 Mn |
| Sep 30, 2018 | 2.63 Mn |
| Jun 30, 2018 | 2.58 Mn |
| Jun 30, 2018 | 2.58 Mn |
| Mar 31, 2018 | 2.20 Mn |
| Mar 31, 2018 | 2.20 Mn |
| Dec 31, 2017 | 45,000.00 |
| Dec 31, 2017 | 45,000.00 |